MONARCH: Chemo-free options for triple-positive metastatic breast cancer

0 Views
administrator
administrator
07/03/23

Evandro de Azambuja, MD, PhD, of the Institut Jules Bordet, Brussels, Belgium, discusses how data from the MONARCH study (NCT02107703) is introducing chemotherapy-free treatment for patients with triple-positive metastatic breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next